Atlas Trials

Study to Investigate Safety and Response to 1 or 2 g Rectal Suppositories Containing 5 or 10 mg NRL001.

Clinical trial NCT00857467 · COMPLETED

Trial details

NCT number
NCT00857467
Sponsor
Norgine
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Fecal Incontinence
Start date
2009-02-01
Primary completion
2009-12-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.